June 30, 2024

December 31, 2023

Assets

Current assets:

Cash and cash equivalents

$

5,504

$

6,518

Short-term investments

2,604

5,124

Accounts receivable and other receivables, net of allowance for doubtful accounts of
   $0 as of June 30, 2024 and December 31, 2023

840

506

Inventories — current

978

837

Assets held for sale

—

51

Note receivable — current

1,759

—

Prepaid expenses and other current assets

537

807

Current assets of discontinued operations — GoodWheat

212

1,129

Total current assets

12,434

14,972

Property and equipment, net

54

70

Right of use asset

513

792

Inventories — noncurrent

191

196

Intangible assets, net

39

39

Note receivable — noncurrent

3,974

-

Other noncurrent assets

164

164

Noncurrent assets of discontinued operations — GoodWheat

—

3,472

Total assets

$

17,369

$

19,705

Liabilities and stockholders’ equity

Current liabilities:

Accounts payable and accrued expenses

$

1,560

$

1,910

Amounts due to related parties

80

58

Operating lease liability — current

563

852

Other current liabilities

255

270

Current liabilities of discontinued operations — GoodWheat

240

500

Total current liabilities

2,698

3,590

Operating lease liability — noncurrent

11

155

Common stock warrant and option liabilities

1,094

1,257

Other noncurrent liabilities

2,000

2,000

Total liabilities

5,803

7,002

Commitments and contingencies (Note 14)

Stockholders’ equity:

Common stock, $0.001 par value—150,000,000 shares authorized; 1,362,840 and 1,285,337
   shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively

65

65

Additional paid-in capital

284,760

284,515

Accumulated other comprehensive income

81

101

Accumulated deficit

(273,202

)

(271,840

)

Total stockholders’ equity

11,704

12,841

Non-controlling interest

(138

)

(138

)

Total stockholders' equity

11,566

12,703

Total liabilities and stockholders’ equity

$

17,369

$

19,705

Three Months Ended June 30,

Six Months Ended June 30,

2024

2023

2024

2023

Revenues:

Product

$

1,306

$

1,287

$

2,293

$

2,369

License

—

10

—

10

Total revenues

1,306

1,297

2,293

2,379

Operating expenses (income):

Cost of revenues

633

650

1,104

1,178

Research and development

10

27

16

40

Gain on sale of intangible assets

(4,000

)

—

(4,000

)

—

Impairment of property and equipment

—

—

36

—

Selling, general and administrative

2,683

2,074

4,745

4,671

Total operating (income) expenses

(674

)

2,751

1,901

5,889

Income (loss) from continuing operations

1,980

(1,454

)

392

(3,510

)

Interest income

150

207

195

405

Other income (loss), net

150

(13

)

153

19

Valuation loss on March 2023 PIPE

—

—

—

(6,076

)

Change in fair value of common stock warrant and option liabilities

(430

)

4,416

163

5,357

Issuance and offering costs allocated to liability classified options

—

—

—

(430

)

Net income (loss) from continuing operations before income taxes

1,850

3,156

903

(4,235

)

Income tax provision

—

(1

)

—

(1

)

Net income (loss) from continuing operations

1,850

3,155

903

(4,236

)

Net loss from discontinued operations — Body Care

—

(330

)

—

(511

)

Net loss from discontinued operations — GoodWheat

(789

)

(2,007

)

(2,265

)

(3,819

)

Net income (loss)

1,061

818

(1,362

)

(8,566

)

Net loss attributable to non-controlling interest

—

(5

)

—

(5

)

Net income (loss) attributable to common stockholders

$

1,061

$

823

$

(1,362

)

$

(8,561

)

Net income (loss) per share attributable to common stockholders:

Basic and diluted from continuing operations

$

1.36

$

2.33

$

0.66

$

(3.81

)

Basic from discontinuing operations

$

(0.58

)

$

(1.71

)

$

(1.66

)

$

(3.90

)

Net income (loss) per basic and diluted share attributable to common stockholders

$

0.78

$

0.61

$

(1.00

)

$

(7.70

)

Weighted-average number of shares used in per share
   calculations:

Basic and diluted

1,362,840

1,358,395

1,362,249

1,111,915

Other comprehensive income, net of tax

Unrealized gains on available-for-sale securities

$

31

$

21

$

91

$

21

Change in unrealized gains on available-for-sale securities

$

(80

)

$

21

$

(20

)

$

21

Comprehensive income (loss)

$

981

$

844

$

(1,382

)

$

(8,540

)

Six Months Ended June 30,

2024

2023

CASH FLOWS FROM OPERATING ACTIVITIES:

Net loss

$

(1,362

)

$

(8,566

)

Adjustments to reconcile net loss to cash used in operating activities:

Change in fair value of common stock warrant and option liabilities

(163

)

(5,357

)

Issuance and offering costs allocated to liability classified options

—

430

Valuation loss on March 2023 PIPE

—

6,076

Depreciation

85

138

Lease amortization

352

357

Amortization of note receivable discount

(29

)

—

Gain on disposal of property and equipment

(89

)

(26

)

Gain on sale of RS durum wheat trait

(4,000

)

—

Stock-based compensation

240

411

Write-down of inventories

—

192

Impairment of property and equipment

36

—

Changes in operating assets and liabilities:

Accounts receivable and other receivables

(334

)

87

Inventories

440

(1,316

)

Prepaid expenses and other current assets

270

(142

)

Other noncurrent assets

—

(13

)

Accounts payable and accrued expenses

(612

)

(149

)

Amounts due to related parties

22

(16

)

Other current liabilities

(15

)

12

Operating lease liabilities

(507

)

(382

)

Net cash used in operating activities

(5,666

)

(8,264

)

CASH FLOWS FROM INVESTING ACTIVITIES:

Proceeds from sale of property and equipment

162

37

Proceeds from sale of Verdeca — earn-out received

—

569

Proceeds from sale of investments

2,501

—

Proceeds from sale of RS durum wheat trait

4,000

—

Cash paid related to sale of GoodWheat

(2,000

)

—

Purchases of property and equipment

(16

)

(5

)

Purchases of investments

—

(5,002

)

Net cash provided by (used in) investing activities

4,647

(4,401

)

CASH FLOWS FROM FINANCING ACTIVITIES:

Proceeds from issuance of common stock, pre-funded warrants and
   preferred investment options from March 2023 PIPE

—

5,997

Payments of offering costs relating to March 2023 PIPE

—

(497

)

Proceeds from ESPP purchases

5

5

Net cash provided by financing activities

5

5,505

Net decrease in cash and cash equivalents

(1,014

)

(7,160

)

Cash and cash equivalents — beginning of period

6,518

20,644

Cash and cash equivalents — end of period

$

5,504

$

13,484

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION

NONCASH INVESTING AND FINANCING ACTIVITIES:

Common stock options issued to placement agent and included in offering
    costs related to March 2023 PIPE

$

—

$

212

Warrant and option modifications included in Valuation loss on March
    2023 PIPE

$

—

$

404

Proceeds from sale of property and equipment in accounts receivable and other receivables

$

84

$

2

Right of use assets obtained in exchange for new operating lease liabilities

$

86

$

—

Note receivable recognized from sale of GoodWheat

$

5,705

$

—